Variant report
Variant | esv3411793 |
---|---|
Chromosome Location | chr14:96934270-96934942 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544011734 | chr14:96934312-96934313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551723436 | chr14:96934322-96934323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139470885 | chr14:96934327-96934328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185225097 | chr14:96934332-96934333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559432003 | chr14:96934403-96934404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139123851 | chr14:96934409-96934410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35563628 | chr14:96934410-96934411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs71103531 | chr14:96934433-96934434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112726152 | chr14:96934442-96934443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574069623 | chr14:96934456-96934457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11624079 | chr14:96934461-96934462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563395001 | chr14:96934548-96934549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71103532 | chr14:96934551-96934552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570223842 | chr14:96934552-96934553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115688991 | chr14:96934610-96934611 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549169933 | chr14:96934615-96934616 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs67009492 | chr14:96934656-96934657 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190827589 | chr14:96934696-96934697 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528431918 | chr14:96934702-96934703 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547374883 | chr14:96934732-96934733 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565768397 | chr14:96934758-96934759 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149237539 | chr14:96934789-96934790 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557800382 | chr14:96934793-96934794 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570145984 | chr14:96934840-96934841 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537203246 | chr14:96934882-96934883 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555976494 | chr14:96934895-96934896 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373720153 | chr14:96934900-96934901 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369513133 | chr14:96934902-96934903 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs60811930 | chr14:96934925-96934926 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs552983223 | chr14:96934926-96934927 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 20164920 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Breast cancer | 21509527 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:96917200-96954800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr14:96929000-96934600 | Weak transcription | Duodenum Mucosa | Duodenum |
3 | chr14:96929400-96946200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr14:96929600-96935000 | Weak transcription | Stomach Mucosa | stomach |
5 | chr14:96929600-96941600 | Weak transcription | Pancreas | Pancrea |
6 | chr14:96932000-96935600 | Enhancers | Fetal Intestine Large | intestine |
7 | chr14:96932800-96934600 | Enhancers | HepG2 | liver |
8 | chr14:96932800-96935800 | Enhancers | Fetal Intestine Small | intestine |
9 | chr14:96932800-96936000 | Enhancers | Liver | Liver |
10 | chr14:96934200-96935800 | Enhancers | Placenta | Placenta |
11 | chr14:96934600-96935600 | Enhancers | Duodenum Mucosa | Duodenum |
12 | chr14:96934600-96935600 | Flanking Active TSS | HepG2 | liver |